Uriel Bohn Sarmiento

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose: To assess the efficacy and the toxicity of a new combination of epirubicin, cyclophosphamide and paclitaxel as neoadjuvant chemotherapy for breast cancer. Methods: Patients with stage II and(More)
  • 1